Returning individual research results in international direct-to-participant genomic research: results from a 31-country study.

Eur J Hum Genet

Faculty of Medicine and Health Sciences, Centre of Genomics and Policy, McGill University, Montreal, QC, Canada.

Published: October 2022

This paper summarizes the results of a 31-country qualitative study of expert perspectives on the regulation of international "direct-to-participant" (DTP) genomic research. We outline how the practice of directly recruiting participants for genomic studies online complicates ethics and regulatory considerations for the return of individual research results. As part of a larger project supported by the National Human Genome Research Institute, National Institutes of Health, we prepared and distributed to 31 global legal experts a questionnaire intended to ascertain opinions and perspectives on the way international DTP genomic research is likely to be regulated. We found significant disagreement across jurisdictions on the most favorable approach to managing such results, with some countries favoring return by default and others preferring to return only with the express consent of research participants. We conclude by outlining policy considerations that should guide researcher practices in this context. As international DTP genomic research evolves, jurists and ethicists should be attentive to the ways novel approaches to subject recruitment align with existing ethical and regulatory norms in research with human participants. This paper is a preliminary step toward documenting such alignment in the context of the return of individual research results.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553878PMC
http://dx.doi.org/10.1038/s41431-022-01103-zDOI Listing

Publication Analysis

Top Keywords

dtp genomic
12
return individual
8
international dtp
8
genomic
5
returning individual
4
international
4
individual international
4
international direct-to-participant
4
direct-to-participant genomic
4
genomic 31-country
4

Similar Publications

\nKlebsiella pneumoniae is a common pathogen of healthcare-associated infections expressing a plethora of antimicrobial resistance loci, including ADP-ribosyltransferase coding genes (arr), able to mediate rifampicin resistance. The latter has activity against a broad range of microorganisms by inhibiting DNA-dependent RNA polymerases. This study aims to characterise the arr distribution and genetic context in 138 clinical isolates of K.

View Article and Find Full Text PDF

Genetic Diversity and Antiretroviral Resistance in HIV-1-Infected Patients Newly Diagnosed in Cabo Verde.

Viruses

December 2024

Global Health and Tropical Medicine, GHTM, Associate Laboratory in Translation and Innovation Towards Global Health, LA-REAL, Instituto de Higiene e Medicina Tropical, IHMT, Universidade NOVA de Lisboa, Rua da Junqueira 100, 1349-008 Lisboa, Portugal.

The high genetic variability of HIV-1 and the emergence of transmitted drug resistance (TDR) can impact treatment efficacy. In this study, we investigated the prevalent HIV-1 genotypes and drug-resistance-associated mutations in drug-naïve HIV-1 individuals in Cabo Verde. The study, conducted between 2018 and 2019, included drug-naïve HIV-1 individuals from the São Vicente, Boa Vista, Fogo, and Santiago islands.

View Article and Find Full Text PDF
Article Synopsis
  • Marine plastispheres are dynamic microhabitats where microorganisms thrive on plastic debris, but their initial formation and interactions are not well understood.
  • This study used metaproteomic and metagenomic techniques to investigate the microbial diversity and biofilm development on low-density polyethylene (LDPE) over 3 and 7 days, identifying key organisms like Pseudomonas and Marinomonas.
  • Findings revealed that Pseudomonas dominated early, while Marinomonas and other genera became more prominent later, showcasing various metabolic pathways and competitive advantages that enhance our understanding of plastisphere ecology and its biotechnological potential.
View Article and Find Full Text PDF

The clinical effectiveness of KRASG12C inhibitors (G12Ci) is limited both by intrinsic and acquired resistance, necessitating the development of combination approaches. Here, we identified targeting proximal receptor tyrosine kinase signaling using the SOS1 inhibitor (SOS1i) BI-3406 as a strategy to improve responses to G12Ci treatment. SOS1i enhanced the efficacy of G12Ci and limited rebound receptor tyrosine kinase/ERK signaling to overcome intrinsic/adaptive resistance, but this effect was modulated by SOS2 protein levels.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!